Benjamin Graham fit · Investimento deep-value defensivo
Is Pacira BioSciences, Inc. Common Stock (PCRX) a Benjamin Graham Stock?
Meets only 2/7 Graham criteria — likely overpriced or unstable.
0/100
FNão encaixa
2/7 critérios atendidos
Os critérios de Benjamin Graham, aplicados a PCRX
P/E ≤ 15
chave—
P/B ≤ 1.5
chave0.0x
Current ratio ≥ 2
—
Debt / Equity ≤ 1
0.0x
Como PCRX pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$918.47M
P/L (TTM)
181.4x
ROIC (TTM)
0.8%
Margem bruta
79.34%
Outras análises Benjamin Graham
Perguntas frequentes
What is PCRX's Benjamin Graham fit score?
PCRX scores 0/100 on our Benjamin Graham fit engine — grade F. Meets only 2/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own PCRX?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends PCRX.
How often is this score updated?
PCRX's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Benjamin Graham possua ou recomende PCRX pessoalmente.